Результаты поиска - Peifen Fu

Отмена результатов
  1. 1
    Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer

    Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer по Weiyang Lou, Bisha Ding, Peifen Fu

    Опубликовано 2020
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  2. 2
    Role of cytoplasmic lncRNAs in regulating cancer signaling pathways

    Role of cytoplasmic lncRNAs in regulating cancer signaling pathways по Peifen Fu, Xin Zheng, Fan Xiao, Aifu Lin

    Опубликовано 2019
    Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  3. 3
    Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro

    Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro по Weiyang Lou, Bisha Ding, Shuqian Wang, Peifen Fu

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells

    Large intergenic non-coding RNA-ROR reverses gemcitabine-induced autophagy and apoptosis in breast cancer cells по Yaomin Chen, Yu Liu, Haiyan Wei, Kezhen Lv, Peifen Fu

    Опубликовано 2016
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    Long Noncoding RNAs, New Critical Regulators in Cancer Immunity

    Long Noncoding RNAs, New Critical Regulators in Cancer Immunity по Minjie Wu, Peifen Fu, Lei Qu, Jian Liu, Aifu Lin

    Опубликовано 2020
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  6. 6
    Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines

    Tanshinone IIA blocks epithelial-mesenchymal transition through HIF-1α downregulation, reversing hypoxia-induced chemotherapy resistance in breast cancer cell lines по Peifen Fu, Feiya Du, Wei Chen, Minya Yao, Kezhen Lv, Yu Liu

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer

    Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer по Weiyang Lou, Bisha Ding, Guansheng Zhong, Chengyong Du, Weimin Fan, Peifen Fu

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis

    The neutrophil lymphocyte ratio is associated with breast cancer prognosis: an updated systematic review and meta-analysis по Bajin Wei, Minya Yao, Chunyang Xing, Wei Wang, Jia Yao, Yun Soo Hong, Yu Liu, Peifen Fu

    Опубликовано 2016
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  9. 9
    Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications

    Exploring the crosstalk between endothelial cells, immune cells, and immune checkpoints in the tumor microenvironment: new insights and therapeutic implications по Jian-Wen Fang, Yue Lu, Jingyan Zheng, Xiaocong Jiang, Haixing Shen, Shang Xi, Yuexin Lu, Peifen Fu

    Опубликовано 2023
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  10. 10
    Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway

    Resveratrol promotes MICA/B expression and natural killer cell lysis of breast cancer cells by suppressing c-Myc/miR-17 pathway по Jie Pan, Jiaying Shen, Wengong Si, Chengyong Du, Danni Chen, Liang Xu, Minya Yao, Peifen Fu, Weimin Fan

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  11. 11
    Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer

    Prognostic value of preoperative inflammatory markers in Chinese patients with breast cancer по Peifen Fu, Minya Yao, Yu Liu, Hailong Jin, Xiaojiao Liu, Kezhen Lv, Haiyan Wei, Chengyong Du, Shuqian Wang, Bajin Wei

    Опубликовано 2014
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer

    Silencing NKG2D ligand-targeting miRNAs enhances natural killer cell-mediated cytotoxicity in breast cancer по Jiaying Shen, Jie Pan, Chengyong Du, Wengong Si, Minya Yao, Liang Xu, Huilin Zheng, Mingjie Xu, Danni Chen, Shu Wang, Peifen Fu, Weimin Fan

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells

    miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells по Danni Chen, Wengong Si, Jiaying Shen, Chengyong Du, Weiyang Lou, Chang Bao, Huilin Zheng, Jie Pan, Guansheng Zhong, Liang Xu, Peifen Fu, Weimin Fan

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells

    Lin28 Mediates Paclitaxel Resistance by Modulating p21, Rb and Let-7a miRNA in Breast Cancer Cells по Kezhen Lv, Liqun Liu, Linbo Wang, Jiren Yu, Xiaojiao Liu, Yongxia Cheng, Min Dong, Rongyue Teng, Linjiao Wu, Peifen Fu, Wuguo Deng, Wenxian Hu, Lisong Teng

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance

    A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance по Wengong Si, Jiaying Shen, Chengyong Du, Danni Chen, Xidong Gu, Chenggong Li, Minya Yao, Jie Pan, Junchi Cheng, Donghai Jiang, Liang Xu, Chang Bao, Peifen Fu, Weimin Fan

    Опубликовано 2017
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ

    OTUB2 Promotes Cancer Metastasis via Hippo-Independent Activation of YAP and TAZ по Zhengkui Zhang, Jinjin Du, Shuai Wang, Li Shao, Ke Jin, Fang Li, Bajin Wei, Wei Ding, Peifen Fu, Hans van Dam, Aijun Wang, Jin Jin, Chen Ding, Bing Yang, Min Zheng, Xin‐Hua Feng, Kun‐Liang Guan, Long Zhang

    Опубликовано 2018
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    lncRNA <i>BREA2</i> promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1

    lncRNA <i>BREA2</i> promotes metastasis by disrupting the WWP2-mediated ubiquitination of Notch1 по Zhen Zhang, Yun‐Xin Lu, Fangzhou Liu, Lingjie Sang, Chengyu Shi, Shaofang Xie, Weixiang Bian, Jiecheng Yang, Zuozhen Yang, Lei Qu, Shiyi Chen, Jun Li, Lu Yang, Qingfeng Yan, Wenqi Wang, Peifen Fu, Jian‐Zhong Shao, Xu Li, Aifu Lin

    Опубликовано 2023
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial

    Neoadjuvant pyrotinib, trastuzumab, and docetaxel for HER2-positive breast cancer (PHEDRA): a double-blind, randomized phase 3 trial по Jiong Wu, Zefei Jiang, Zhenzhen Liu, Benlong Yang, Hongjian Yang, Jinhai Tang, Kun Wang, Yunjiang Liu, Haibo Wang, Peifen Fu, Shuqun Zhang, Qiang Liu, Shusen Wang, Jian Huang, Chuan Wang, Shu Wang, Yongsheng Wang, Linlin Zhen, Xiaoyu Zhu, Fei Wu, Xiang Lin, Jianjun Zou

    Опубликовано 2022
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021

    Trends in Disparities and Transitions of Treatment in Patients With Early Breast Cancer in China and the US, 2011 to 2021 по Jianbin Li, Jifang Zhou, Haibo Wang, Zhenzhen Liu, Zhimin Fan, Yinhua Liu, Cuizhi Geng, Yue Xiao, Zefei Jiang, Yunjiang Liu, Yuhua Song, Min Yan, Qianjun Chen, Ying Lin, Qiang Liu, Feng Jin, Yuee Teng, Peifen Fu, Jianguo Zhang, Zhigao Li, Yiding Chen, Kun Wang, Yongmei Yin, Xiaoming Zha, Haiqing Zhang

    Опубликовано 2023
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020

    Suboptimal declines and delays in early breast cancer treatment after COVID-19 quarantine restrictions in China: A national survey of 8397 patients in the first quarter of 2020 по Jianbin Li, Haibo Wang, Cuizhi Geng, Zhenzhen Liu, Ying Lin, Jianyun Nie, Gang Sun, Quchang Ouyang, Xiao‐Jia Wang, Xingrui Li, Yinhua Liu, Qianjun Chen, Peifen Fu, Feng Yao, Jishang Chen, Yiding Chen, Haidong Zhao, Yongmei Yin, Jingjie Zhang, Jiayi Chen, Xiangshun Kong, Jing Cheng, Haiqing Zhang, Shijun Peng, Geng Wang, Feng Jin, Yunjiang Liu, Gang Wu, Shengrong Sun, Zefei Jiang

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: